BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 29884437)

  • 21. Use of carboplatin in germ cell tumors of the testis.
    Horwich A; Mason M; Dearnaley DP
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):72-7. PubMed ID: 1329224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group.
    Williams SD; Blessing JA; Hatch KD; Homesley HD
    J Clin Oncol; 1991 Nov; 9(11):1950-5. PubMed ID: 1719142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary.
    Talukdar S; Kumar S; Bhatla N; Mathur S; Thulkar S; Kumar L
    Gynecol Oncol; 2014 Jan; 132(1):28-32. PubMed ID: 24145115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
    Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
    Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of ovarian germ cell tumors: ten years of experience at the Brazilian National Cancer Institute.
    Lopes da Silva J; Luiz Renna N; Paulino E; de Melo AC
    Int J Gynecol Cancer; 2015 Jun; 25(5):786-91. PubMed ID: 25790041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study.
    Dimopoulos MA; Papadopoulou M; Andreopoulou E; Papadimitriou C; Pavlidis N; Aravantinos G; Aspropotamitis A; Anagnostopoulos A; Fountzilas G; Michalas S; Pectacides D
    Gynecol Oncol; 1998 Jul; 70(1):70-4. PubMed ID: 9698477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical analysis of 15 cases of malignant ovarian germ cell tumors with lung metastasis].
    Liu Y; Ren T; Feng FZ; Wan XR; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):40-4. PubMed ID: 22455692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comprehensive staging surgery in treatment of malignant ovarian germ cell tumor].
    Jin Y; Pan LY; Huang HF; Shen K; Wu M; Yang JX; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):826-30. PubMed ID: 16412329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of adolescent males with extracranial metastatic germ cell tumors: A report from the Malignant Germ Cell Tumor International Consortium.
    Shaikh F; Stark D; Fonseca A; Dang H; Xia C; Krailo M; Pashankar F; Rodriguez-Galindo C; Olson TA; Nicholson JC; Murray MJ; Amatruda JF; Billmire D; Stoneham S; Frazier AL
    Cancer; 2021 Jan; 127(2):193-202. PubMed ID: 33079404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PVB chemotherapy in patients with recurrent or advanced dysgerminoma: a Phase II study of the EORTC Gynaecological Cancer Cooperative Group.
    Pawinski A; Favalli G; Ploch E; Sahmoud T; van Oosterom AT; Pecorelli S
    Clin Oncol (R Coll Radiol); 1998; 10(5):301-5. PubMed ID: 9848330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
    Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
    J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Malignant ovarian germ cell tumors--clinical characteristics and analysis of outcomes].
    Miedzińska-Maciejewska M; Bobkiewicz P; Gawrychowski K
    Ginekol Pol; 2011 May; 82(5):338-43. PubMed ID: 21851031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian Yolk Sac Tumors; Does Age Matter?
    Faure Conter C; Xia C; Gershenson D; Hurteau J; Covens A; Pashankar F; Krailo M; Billmire D; Patte C; Fresneau B; Shaikh F; Stoneham S; Nicholson J; Murray M; Frazier AL
    Int J Gynecol Cancer; 2018 Jan; 28(1):77-84. PubMed ID: 29194189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer.
    Gray HJ; Shah CA; Swensen RE; Tamimi HK; Goff BA
    Gynecol Oncol; 2010 Mar; 116(3):340-4. PubMed ID: 19922987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
    Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group.
    Shaikh F; Cullen JW; Olson TA; Pashankar F; Malogolowkin MH; Amatruda JF; Villaluna D; Krailo M; Billmire DF; Rescorla FJ; Egler RA; Dicken BJ; Ross JH; Schlatter M; Rodriguez-Galindo C; Frazier AL
    J Clin Oncol; 2017 Apr; 35(11):1203-1210. PubMed ID: 28240974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study.
    Chu R; Liu P; Chen J; Cheng X; Li K; Che Y; Wang J; Li L; Zhang X; Yao S; Song L; Zhao Y; Huang C; Xue Y; Pan X; Li J; Chen Z; Jiang J; Kong B; Song K
    J Gynecol Oncol; 2023 Mar; 34(2):e12. PubMed ID: 36890292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.
    Billmire DF; Cullen JW; Rescorla FJ; Davis M; Schlatter MG; Olson TA; Malogolowkin MH; Pashankar F; Villaluna D; Krailo M; Egler RA; Rodriguez-Galindo C; Frazier AL
    J Clin Oncol; 2014 Feb; 32(5):465-70. PubMed ID: 24395845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin.
    Gershenson DM; Morris M; Cangir A; Kavanagh JJ; Stringer CA; Edwards CL; Silva EG; Wharton JT
    J Clin Oncol; 1990 Apr; 8(4):715-20. PubMed ID: 1690272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience.
    Segelov E; Campbell J; Ng M; Tattersall M; Rome R; Free K; Hacker N; Friedlander ML
    J Clin Oncol; 1994 Feb; 12(2):378-84. PubMed ID: 8113845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.